×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Juvenile Myelomonocytic Leukemia
1.000
SomaticCausalMutation
ORPHANET
Juvenile myelomonocytic leukemia (JMML ) is an intractable pediatric leukemia with poor prognosis whose molecular pathogenesis is poorly understood, except for somatic or germline mutations of RAS pathway genes, including PTPN11, NF1, NRAS, KRAS and CBL, in the majority of cases.
23832011
2013
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Juvenile Myelomonocytic Leukemia
1.000
SomaticCausalMutation
ORPHANET
Molecular basis of juvenile myelomonocytic leukemia.
20139388
2010
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Noonan Syndrome
1.000
GermlineCausalMutation
ORPHANET
Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype.
16773572
2006
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Cardio-facio-cutaneous syndrome
0.800
GermlineCausalMutation
ORPHANET
The cardiofaciocutaneous syndrome.
16825433
2006
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Organoid Nevus Phakomatosis
0.750
SomaticCausalMutation
ORPHANET
Mosaicism for HRAS c.37G>C and KRAS c.35G>A mutations was found in two individuals with Schimmelpenning syndrome .
22683711
2012
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER
0.630
SomaticCausalMutation
ORPHANET
Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis.
21079152
2011
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Nevus sebaceous
0.430
SomaticCausalMutation
ORPHANET
Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
22683711
2012
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Papillary thyroid carcinoma
0.400
SomaticCausalMutation
ORPHANET
RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
25109485
2015
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Papillary thyroid carcinoma
0.400
SomaticCausalMutation
ORPHANET
Preoperative RAS mutational analysis is of great value in predicting follicular variant of papillary thyroid carcinoma.
25648502
2015
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Papillary thyroid carcinoma
0.400
SomaticCausalMutation
ORPHANET
Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.
25132659
2014
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Papillary thyroid carcinoma
0.400
SomaticCausalMutation
ORPHANET
BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma.
23625203
2013
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Hereditary Nonpolyposis Colorectal Cancer
0.400
Biomarker
ORPHANET
Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer.
19731079
2010
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
APLASIA CUTIS CONGENITA WITH EPIBULBAR DERMOIDS
0.330
SomaticCausalMutation
ORPHANET
Oculoectodermal syndrome is a mosaic RASopathy associated with KRAS alterations.
25808193
2015
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Encephalocraniocutaneous lipomatosis
0.310
GeneticVariation
ORPHANET
Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis .
26970110
2016
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Pancreatic carcinoma, familial
0.310
SusceptibilityMutation
ORPHANET
Familial and sporadic pancreatic cancer share the same molecular pathogenesis.
25240578
2015
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Pilomyxoid astrocytoma
0.300
SomaticCausalMutation
ORPHANET
MAPK pathway activation in pilocytic astrocytoma.
22159586
2012
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Pilomyxoid astrocytoma
0.300
SomaticCausalMutation
ORPHANET
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.
21424530
2011
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Hereditary non-polyposis colorectal cancer syndrome
0.300
Biomarker
ORPHANET
Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer.
19731079
2010
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Pilomyxoid astrocytoma
0.300
SomaticCausalMutation
ORPHANET
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.
19373855
2009
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Pilomyxoid astrocytoma
0.300
SomaticCausalMutation
ORPHANET
Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
17712732
2007